Cerner Enviza
  • ABOUT US
  • THOUGHT LEADERSHIP
  • CAREERS
  • GET IN TOUCH
  • Commercialization

    Commercializing by Brands

    • Brand and Marketing Strategy for Life Sciences
    • Commercial Insight for Life Sciences
    • Corporate Reputation Management for Pharma
    • Patient, Physician and Payer Insights
    • Scientific Assessment

    Therapy Specializations

    • Oncology Consulting
    • Rare Disease Consulting
  • RWE Data & Analytics

    RWE Data & Analytics

    • Market Access
    • Real World Data
    • Patient Reported Outcomes
    • Syndicated Reports and Insights for Life Sciences
    • Real-World Qualitative
    • Stakeholder Preference Studies

    Therapy Specializations

    • Oncology Consulting
    • Rare Disease Consulting
  • Clinical, Regulatory & Safety

    Clinical, Regulatory & Safety

    • Registries
    • Late Phase Research
    • Post-Marketing Clinical Follow-Up (PMCF)
    • Non-Interventional Studies
    • Risk-Benefit Optimization

    Therapy Specializations

    • Oncology Consulting
    • Rare Disease Consulting
  • Therapy Specializations

    Therapy Specializations

    • Oncology Consulting
    • Rare Disease Consulting
  1. Home
    >
  2. Newsroom
    >

News Releases

April 26, 2022

The International Gaucher Alliance and Cerner Enviza enroll first patient in GARDIAN registry

January 24, 2022

Cerner and ZEG Berlin Raise Awareness to Accelerate the Understanding of Endometriosis, Adenomyosis and Myoma

October 26, 2021

Cerner Enviza Aims to Accelerate Therapies and Improve Patient Outcomes

April 1, 2021

Cerner Finalizes Acquisition of Kantar Health

Dec 16, 2020

Cerner Announces Agreement to Acquire Health Division of Kantar

 

For media inquiries and interview requests, please contact mediarelations@cerner.com.

Global Office

2800 Rock Creek Pkwy
North Kansas City, MO 64117
United States
 

English

Commercialization

  • Brand and Marketing Strategy for Life Sciences
  • Commercial Insight for Life Sciences
  • Corporate Reputation Management for Pharma
  • Patient Physician and Payer Insights
  • Scientific Assessment

RWE Data & Analytics

  • Market Access
  • Real World Data
  • Patient Reported Outcomes
  • Syndicated Reports and Insights for Life Sciences
  • Real-World Qualitative
  • Stakeholder Preference Studies
  • France Gender Equality Index

Clinical, Regulatory & Safety

  • Registries
  • Late Phase Research
  • Post-Marketing Clinical Follow-Up
  • Non Interventional Studies
  • Risk-Benefit Optimization

Therapy Specializations

  • Oncology Consulting
  • Rare Disease Consulting

Follow Us

© 2022 Cerner Corporation. All Rights Reserved.
About Us
Thought Leadership
Careers
Get in touch
Terms and Conditions
Cookie Policy
Privacy Notice
Newsroom